21-46391269-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000359568.10(PCNT):c.4109G>A(p.Arg1370Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000308 in 1,596,248 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1370W) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000359568.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCNT | NM_006031.6 | c.4109G>A | p.Arg1370Gln | missense_variant | 21/47 | ENST00000359568.10 | NP_006022.3 | |
PCNT | NM_001315529.2 | c.3755G>A | p.Arg1252Gln | missense_variant | 21/47 | NP_001302458.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCNT | ENST00000359568.10 | c.4109G>A | p.Arg1370Gln | missense_variant | 21/47 | 1 | NM_006031.6 | ENSP00000352572 | P2 | |
PCNT | ENST00000480896.5 | c.3755G>A | p.Arg1252Gln | missense_variant | 21/47 | 1 | ENSP00000511989 | A2 | ||
PCNT | ENST00000695558.1 | c.4109G>A | p.Arg1370Gln | missense_variant | 21/48 | ENSP00000512015 | A2 | |||
PCNT | ENST00000703224.1 | c.*3352G>A | 3_prime_UTR_variant, NMD_transcript_variant | 23/49 | ENSP00000515242 |
Frequencies
GnomAD3 genomes AF: 0.000565 AC: 86AN: 152200Hom.: 3 Cov.: 33
GnomAD3 exomes AF: 0.000328 AC: 70AN: 213462Hom.: 0 AF XY: 0.000303 AC XY: 35AN XY: 115334
GnomAD4 exome AF: 0.000281 AC: 406AN: 1443930Hom.: 1 Cov.: 32 AF XY: 0.000257 AC XY: 184AN XY: 716324
GnomAD4 genome AF: 0.000565 AC: 86AN: 152318Hom.: 3 Cov.: 33 AF XY: 0.000403 AC XY: 30AN XY: 74478
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 05, 2022 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1370 of the PCNT protein (p.Arg1370Gln). This variant is present in population databases (rs145055342, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with PCNT-related conditions. ClinVar contains an entry for this variant (Variation ID: 195605). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 22, 2015 | - - |
Microcephalic osteodysplastic primordial dwarfism type II Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jun 19, 2020 | - - |
PCNT-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 24, 2024 | The PCNT c.4109G>A variant is predicted to result in the amino acid substitution p.Arg1370Gln. To our knowledge, this variant has not been reported in individuals with PCNT-associated disorders in the literature. This variant is reported in 0.11% of alleles in individuals of European (Finnish) descent in gnomAD, which may be too common to be an undocumented primary cause of disease. Although we suspect this variant may be benign, at this time, its clinical significance is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at